Serreze D V, Leiter E H
Jackson Laboratory, Bar Harbor, ME 04609.
J Immunol. 1988 Jun 1;140(11):3801-7.
Nonobese diabetic (NOD) is an inbred mouse strain susceptible to development of T cell-mediated autoimmune diabetes. The strain is characterized by high percentages of T lymphocytes in lymphoid organs. The syngeneic mixed lymphocyte reaction (SMLR), a T cell response to self MHC class II Ag, is reportedly involved in the generation of a number of immunoregulatory cells, including suppressor inducers. A severely depressed SMLR characteristic of certain other autoimmune strains was found in NOD but not in nonautoimmune SWR/Bm mice. Moreover, IL-2 produced by NOD T cells at day 6 in an SMLR was at least one hundredfold reduced compared with SWR, and NOD T cells harvested from an SMLR at day 6 were functionally defective when tested for ability to induce suppression of an allogeneic MLR. However, functionally competent suppressor T cells were generated in NOD splenic leukocyte cultures in response to Con A, and IL-2 release from these was equivalent to that released by Con A-stimulated SWR splenocytes. A deficiency in cytokine release was not limited to IL-2, because peritoneal exudate cells from NOD exhibited a greatly diminished sensitivity to LPS-stimulated IL-1 release in comparison to SWR mice. IL-2 supplementation both in vitro and in vivo restored the ability of NOD T cells to respond in a SMLR, with production of cells capable of inducing suppression. Like SMLR-activated T cells from untreated SWR controls, SMLR blasts from IL-2-treated NOD mice were enriched for the L3T4 phenotype. IL-1 supplementation in vitro resulted in partial restoration of T suppressor activation in a SMLR. The depressed SMLR exhibited by NOD mice was apparently a stimulator cell dysfunction, because NOD stimulator cells failed to activate T cells from (SWR x NOD)F1 mice, whereas stimulators from SWR or F1 mice were capable of doing so. Collectively, these results suggest a defect in suppressor cell activation rather than an absence of this immunoregulatory cell population.
非肥胖型糖尿病(NOD)小鼠是一种近交系小鼠,易患T细胞介导的自身免疫性糖尿病。该品系的特点是淋巴器官中T淋巴细胞比例较高。据报道,同基因混合淋巴细胞反应(SMLR),即T细胞对自身MHC II类抗原的反应,参与了包括抑制诱导细胞在内的多种免疫调节细胞的产生。在NOD小鼠中发现了某些其他自身免疫品系所特有的严重抑制的SMLR,但在非自身免疫的SWR/Bm小鼠中未发现。此外,与SWR相比,NOD T细胞在SMLR第6天产生的IL-2减少了至少100倍,并且当检测从SMLR第6天收获的NOD T细胞诱导同种异体MLR抑制的能力时,发现其功能有缺陷。然而,在NOD脾白细胞培养物中,响应Con A可产生功能正常的抑制性T细胞,并且这些细胞释放的IL-2与Con A刺激的SWR脾细胞释放的IL-2相当。细胞因子释放缺陷并不局限于IL-2,因为与SWR小鼠相比,NOD的腹腔渗出细胞对LPS刺激的IL-1释放的敏感性大大降低。体外和体内补充IL-2均恢复了NOD T细胞在SMLR中的反应能力,并产生了能够诱导抑制的细胞。与未处理的SWR对照的SMLR激活T细胞一样,IL-2处理的NOD小鼠的SMLR母细胞富含L3T4表型。体外补充IL-1导致SMLR中T抑制细胞激活的部分恢复。NOD小鼠表现出的SMLR抑制显然是刺激细胞功能障碍,因为NOD刺激细胞无法激活(SWR×NOD)F1小鼠的T细胞,而SWR或F1小鼠的刺激细胞则能够激活。总体而言,这些结果表明抑制细胞激活存在缺陷,而不是缺乏这种免疫调节细胞群体。